Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: a multicentre US study. (abre nova janela)

Al-Samkari H, Jiang D, Gernsheimer T, Liebman H, Lee S, Wojdyla M, Vredenburg M, Cuker A

Fonte‎: Br J Haematol. 2022;197(3):359-66.

Indexado‎: PubMed 35179784

DOI‎: 10.1111/bjh.18081

https://pubmed.ncbi.nlm.nih.gov/35179784/ (abre nova janela)

Efficacy of high-dose methylprednisolone as a first-line therapy in adult patients with idiopathic thrombocytopenic purpura. (abre nova janela)

Alpdogan O, Budak-Alpdogan T, Ratip S, Firatli-Tuglular T, Tanriverdi S, Karti S, Bayik M, Akoglu T.

Fonte‎: Br J Haematol 1998;103(4):1061-3.

Indexado‎: PubMed 9886319

https://www.ncbi.nlm.nih.gov/pubmed/9886319 (abre nova janela)

Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. (abre nova janela)

Arnold DM, Dentali F, Crowther MA, Meyer RM, Cook RJ, Sigouin C, Fraser GA, Lim W, Kelton JG.

Fonte‎: Ann Intern Med 2007;146(1):25-33.

Indexado‎: PubMed 17200219

https://www.ncbi.nlm.nih.gov/pubmed/17200219 (abre nova janela)

Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial. (abre nova janela)

Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Amini S, Schipperus M, Lim W, Vishnu P, Warner M, Carruthers J, Li N, Lane S, Kelton JG

Fonte‎: Lancet Haematol 2020;7(9):e640-8.

Indexado‎: PubMed 32853584

DOI‎: 10.1016/S2352-3026(20)30227-1

https://www.ncbi.nlm.nih.gov/pubmed/32853584 (abre nova janela)

A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. (abre nova janela)

Blanchette VS, Luke B, Andrew M, Sommerville-Nielsen S, Barnard D, de Veber B, Gent M.

Fonte‎: J Pediatr 1993;123(6):989-95.

Indexado‎: PubMed 8229536

https://www.ncbi.nlm.nih.gov/pubmed/8229536 (abre nova janela)

High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults. (abre nova janela)

Borst F, Keuning JJ, van Hulsteijn H, Sinnige H, Vreugdenhil G.

Fonte‎: Ann Hematol 2004;83(12):764-8.

Indexado‎: PubMed 15309522

DOI‎: 10.1007/s00277-004-0908-1

https://www.ncbi.nlm.nih.gov/pubmed/15309522 (abre nova janela)

Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. (abre nova janela)

British Committee for Standards in Haematology General Haematology Task Force.

Fonte‎: Br J Haematol 2003;120(4):574-96.

Indexado‎: PubMed 12588344

https://www.ncbi.nlm.nih.gov/pubmed/12588344 (abre nova janela)

IVMP+IVIG raises platelet counts faster than IVIG alone: results of a randomized, blinded trial in childhood ITP. (abre nova janela)

Carcao M, Silva M, David M, Klaassen RJ, Steele M, Price V, Wakefield C, Kim L, Stephens D, Blanchette VS

Fonte‎: Blood Adv 2020;4(7):1492-1500.

Indexado‎: PubMed 32282882

DOI‎: 10.1182/bloodadvances.2019001343

https://www.ncbi.nlm.nih.gov/pubmed/32282882 (abre nova janela)

Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone. (abre nova janela)

Cheng Y, Wong RS, Soo YO, Chui CH, Lau FY, Chan NP, Wong WS, Cheng G.

Fonte‎: N Engl J Med 2003;349(9):831-6.

Indexado‎: PubMed 12944568

DOI‎: 10.1056/NEJMoa030254

https://www.ncbi.nlm.nih.gov/pubmed/12944568 (abre nova janela)

How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment. (abre nova janela)

Ghanima W, Godeau B, Cines DB, Bussel JB.

Fonte‎: Blood 2012;120(5):960-9.

Indexado‎: PubMed 22740443

DOI‎: 10.1182/blood-2011-12-309153

https://www.ncbi.nlm.nih.gov/pubmed/22740443 (abre nova janela)

Use of eltrombopag for secondary immune thrombocytopenia in clinical practice. (abre nova janela)

González-López TJ, Alvarez-Román MT, Pascual C, Sánchez-González B, Fernández-Fuentes F, Pérez-Rus G, Hernández-Rivas JA, Bernat S, Bastida JM, Martínez-Badas MP, Martínez-Robles V, Soto I, Olivera P, Bolaños E, Alonso R, Entrena L, Gómez-Nuñez M, Alonso A, Yera Cobo M, Caparrós I, Tenorio M, Arrieta-Cerdán E, Lopez-Ansoar E, García-Frade J, González-Porras JR

Fonte‎: Br J Haematol 2017;178(6):959-70.

Indexado‎: PubMed 28573819

DOI‎: 10.1111/bjh.14788

https://www.ncbi.nlm.nih.gov/pubmed/28573819 (abre nova janela)

Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. (abre nova janela)

Kojouri K, Vesely SK, Terrell DR, George JN.

Fonte‎: Blood 2004;104(9):2623-34.

Indexado‎: PubMed 15217831

DOI‎: 10.1182/blood-2004-03-1168

https://www.ncbi.nlm.nih.gov/pubmed/15217831 (abre nova janela)

Romiplostim or standard of care in patients with immune thrombocytopenia. (abre nova janela)

Kuter DJ, Rummel M, Boccia R, Macik BG, Pabinger I, Selleslag D, Rodeghiero F, Chong BH, Wang X, Berger DP.

Fonte‎: N Engl J Med 2010;363(20):1889-99.

Indexado‎: PubMed 21067381

DOI‎: 10.1056/NEJMoa1002625

https://www.ncbi.nlm.nih.gov/pubmed/21067381 (abre nova janela)

Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience. (abre nova janela)

Mazzucconi MG, Fazi P, Bernasconi S, De Rossi G, Leone G, Gugliotta L, Vianelli N, Avvisati G, Rodeghiero F, Amendola A, Baronci C, Carbone C, Quattrin S, Fioritoni G, D'Alfonso G, Mandelli F; Gruppo Italiano Malattie EMatologiche dell'Adulto (GIMEMA) Thrombocytopenia Working Party.

Fonte‎: Blood 2007;109(4):1401-7.

Indexado‎: PubMed 17077333

DOI‎: 10.1182/blood-2005-12-015222

https://www.ncbi.nlm.nih.gov/pubmed/17077333 (abre nova janela)

The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. (abre nova janela)

Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA; American Society of Hematology.

Fonte‎: Blood 2011;117(16):4190-207.

Indexado‎: PubMed 21325604

DOI‎: 10.1182/blood-2010-08-302984

https://www.ncbi.nlm.nih.gov/pubmed/21325604 (abre nova janela)

American Society of Hematology 2019 guidelines for immune thrombocytopenia. (abre nova janela)

Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, Cuker A, Despotovic JM, George JN, Grace RF, Kühne T, Kuter DJ, Lim W, McCrae KR, Pruitt B, Shimanek H, Vesely SK

Fonte‎: Blood Adv 2019;3(23):3829-66.

Indexado‎: PubMed 31794604

DOI‎: 10.1182/bloodadvances.2019000966

https://www.ncbi.nlm.nih.gov/pubmed/31794604 (abre nova janela)

International consensus report on the investigation and management of primary immune thrombocytopenia. (abre nova janela)

Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter DJ.

Fonte‎: Blood 2010;115(2):168-86.

Indexado‎: PubMed 19846889

DOI‎: 10.1182/blood-2009-06-225565

https://www.ncbi.nlm.nih.gov/pubmed/19846889 (abre nova janela)

Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients. (abre nova janela)

Scaradavou A, Woo B, Woloski BM, Cunningham-Rundles S, Ettinger LJ, Aledort LM, Bussel JB.

Fonte‎: Blood 1997;89(8):2689-700.

Indexado‎: PubMed 9108386

https://www.ncbi.nlm.nih.gov/pubmed/9108386 (abre nova janela)